Identifying 2PHDO as a SOCE inhibitor from Chinese herbal extracts
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
BACKGROUND: STIM- and Orai-mediated store operated calcium entry (SOCE) is a ubiquitous Ca2+ signaling process, crucial for the proper function of immune, muscle and neuronal systems. To treat SOCE-related disorder or diseases of these systems, and to mechanistically dissect activation and function of SOCE, specific SOCE inhibitors are needed. However, strategies for developing new SOCE modifiers are still limited. <P/> Methodology: In this study, we identified a novel SOCE inhibitor named 2PHDO from a small pool of Chinese herbal extracts used for treating psoriasis. It could block SOCE and SOCE-mediated NFAT translocation in multiple types of cells with a half inhibitory concentration around 1 µM. At this concentration, 2PHDO was specific for SOCE. Mechanistically, 2PHDO didn't affect the activation of STIM1 or its physical coupling with Orai1. Rather, 2PHDO inhibited SOCE via its actions on Orai1. <P/> Results: 2PHDO may serve as a good template for developing new medicines aiming to treat SOCE related diseases. <P/> Conclusion: Overall, we proved the feasibility of screening and identification of novel SOCE inhibitors from active monomers of Chinese herbal medicine.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Current pharmaceutical biotechnology - (2023) vom: 14. Juni |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Liu, Jindou [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2PHDO |
|---|
| Anmerkungen: |
Date Revised 15.06.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.2174/1389201024666230614113457 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358195225 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358195225 | ||
| 003 | DE-627 | ||
| 005 | 20231226074227.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1389201024666230614113457 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1193.xml |
| 035 | |a (DE-627)NLM358195225 | ||
| 035 | |a (NLM)37317920 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Liu, Jindou |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Identifying 2PHDO as a SOCE inhibitor from Chinese herbal extracts |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 15.06.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a BACKGROUND: STIM- and Orai-mediated store operated calcium entry (SOCE) is a ubiquitous Ca2+ signaling process, crucial for the proper function of immune, muscle and neuronal systems. To treat SOCE-related disorder or diseases of these systems, and to mechanistically dissect activation and function of SOCE, specific SOCE inhibitors are needed. However, strategies for developing new SOCE modifiers are still limited. <P/> Methodology: In this study, we identified a novel SOCE inhibitor named 2PHDO from a small pool of Chinese herbal extracts used for treating psoriasis. It could block SOCE and SOCE-mediated NFAT translocation in multiple types of cells with a half inhibitory concentration around 1 µM. At this concentration, 2PHDO was specific for SOCE. Mechanistically, 2PHDO didn't affect the activation of STIM1 or its physical coupling with Orai1. Rather, 2PHDO inhibited SOCE via its actions on Orai1. <P/> Results: 2PHDO may serve as a good template for developing new medicines aiming to treat SOCE related diseases. <P/> Conclusion: Overall, we proved the feasibility of screening and identification of novel SOCE inhibitors from active monomers of Chinese herbal medicine | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a 2PHDO | |
| 650 | 4 | |a Chinese herbal medicine | |
| 650 | 4 | |a Orai1 | |
| 650 | 4 | |a SOCE | |
| 650 | 4 | |a STIM1 | |
| 650 | 4 | |a inhibitor | |
| 700 | 1 | |a Deng, Hao |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Yaxin |e verfasserin |4 aut | |
| 700 | 1 | |a Du, Yangchun |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Liuqing |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yuqing |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Jin |e verfasserin |4 aut | |
| 700 | 1 | |a Xi, Chao |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, Ping |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Yandong |e verfasserin |4 aut | |
| 700 | 1 | |a Han, Ling |e verfasserin |4 aut | |
| 700 | 1 | |a Gill, Donald L |e verfasserin |4 aut | |
| 700 | 1 | |a Lu, Chuanjian |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Youjun |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current pharmaceutical biotechnology |d 2000 |g (2023) vom: 14. Juni |w (DE-627)NLM11369072X |x 1873-4316 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:14 |g month:06 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1389201024666230614113457 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 14 |c 06 | ||